Giovanni Benfari,Davide Margonato,Marco Metra et al.
Giovanni Benfari et al.
Functional/Secondary tricuspid regurgitation (STR) accounts for over 85% of clinically significant tricuspid regurgitation (TR) and is associated with adverse prognosis and impaired quality of life. Advances in percutaneous tricuspid valve ...
Transcatheter tricuspid valve treatment: a growing armamentarium of devices [0.03%]
经导管三尖瓣治疗：不断发展的介入器械选择
Rodrigo Estevez-Loureiro,Julio Echarte-Morales,Nicole Karam et al.
Rodrigo Estevez-Loureiro et al.
Tricuspid regurgitation is a frequent and undertreated condition associated with poor outcomes. Over the past decade, transcatheter tricuspid valve interventions have emerged as a valuable alternative for high-risk patients. Edge-to-edge re...
Georg Nickenig,Marcel Weber,Rebecca T Hahn et al.
Georg Nickenig et al.
Only recently, pathophysiology and relevance of tricuspid regurgitation (TR) has been acknowledged but remains still poorly understood. The rising interest in this valve disease has also fuelled the efforts to define and improve imaging mod...
Helge Möllmann,Marcel Weber,Maria Isabel Körber et al.
Helge Möllmann et al.
Tricuspid regurgitation (TR) affects approximately 4% of individuals over 75 years of age and is associated with substantial morbidity due to heart failure symptoms and frequent hospitalization. In Europe, TR prevalence is expected to rise ...
2025 ESC/EACTS valvular heart disease guidelines: practical updates on mitral and tricuspid regurgitation [0.03%]
2025年ESC/EACTS瓣膜性心脏病指南：二尖瓣和三尖瓣反流治疗的实用更新
Marianna Adamo,Mauro Massussi,Nina Ajmone Marsan et al.
Marianna Adamo et al.
2025 ESC/EACTS guidelines for valvular heart disease reflect the rapid evolution of transcatheter technologies and multidisciplinary care. In primary mitral regurgitation, surgical repair remains the gold standard, with a new Class I recomm...
Reframing tricuspid regurgitation in Europe: from marker of risk to therapeutic target [0.03%]
欧洲三尖瓣反流的再思考：从风险标志到治疗目标
Erwan Donal,Prayuth Rasmeehirun,Marina Petersen Saadi et al.
Erwan Donal et al.
Tricuspid regurgitation (TR), once considered a passive marker of advanced cardiac disease, is increasingly recognized as an independent contributor to morbidity, mortality, and healthcare burden. Recent evidence, including the pivotal TRIL...
Marianna Adamo,Mauro Massussi,Gianluigi Savarese et al.
Marianna Adamo et al.
Tricuspid regurgitation (TR) is a common yet often overlooked valvular disorder that carries a substantial impact on morbidity and mortality. It is increasingly recognized as a heterogeneous entity with different phenotypes identified (prim...
Josè Luis Zamorano,Pieter van der Bijl,Ariana González Gómez et al.
Josè Luis Zamorano et al.
Tricuspid regurgitation (TR) has historically been under-recognized in clinical practice, yet growing evidence highlights its significant impact on prognosis, particularly in its severe forms. Severe TR is indeed associated with increased m...
Daily issues in the life of adults with congenital heart disease: new insights from EURO-ACHD Congress 2025 [0.03%]
成人先天性心脏病患者的日常生活问题：来自EURO-ACHD 2025大会的新见解
Alexandra C van Dissel,Philip Moons,Pastora Gallego et al.
Alexandra C van Dissel et al.
In recent years, remarkable advancements in paediatric cardiology and surgical techniques have dramatically increased the survival of patients with congenital heart disease. As a result, adults with congenital heart disease (ACHD) are now l...